| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | AGAP5 MYO1E ATP11C IDE AGAP11 KATNAL1 AGAP9 AGAP7P AGAP4 DNAH8 TAP2 ABCG8 MFN1 MOV10 KIF1C | 5.27e-07 | 775 | 82 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | AGAP5 MYO1E ATP11C IDE AGAP11 KATNAL1 AGAP9 AGAP7P AGAP4 DNAH8 TAP2 ABCG8 MFN1 MOV10 KIF1C | 1.42e-06 | 839 | 82 | 15 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | AGAP5 MYO1E ATP11C IDE AGAP11 KATNAL1 AGAP9 AGAP7P AGAP4 DNAH8 TAP2 ABCG8 MFN1 MOV10 KIF1C | 1.45e-06 | 840 | 82 | 15 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | AGAP5 MYO1E ATP11C IDE AGAP11 KATNAL1 AGAP9 AGAP7P AGAP4 DNAH8 TAP2 ABCG8 MFN1 MOV10 KIF1C | 1.45e-06 | 840 | 82 | 15 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 8.11e-05 | 441 | 82 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | kainate selective glutamate receptor activity | 2.47e-04 | 6 | 82 | 2 | GO:0015277 | |
| GeneOntologyMolecularFunction | fatty acid elongase activity | 3.45e-04 | 7 | 82 | 2 | GO:0009922 | |
| GeneOntologyMolecularFunction | enzyme activator activity | AGAP5 CDK5R1 FGF13 AGAP11 MARK2 AGAP9 AGAP7P CCNQ AGAP4 PREX2 | 3.48e-04 | 656 | 82 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | ATP-dependent activity | 9.21e-04 | 614 | 82 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.02e-03 | 279 | 82 | 6 | GO:0005096 | |
| GeneOntologyMolecularFunction | GTP binding | 1.23e-03 | 397 | 82 | 7 | GO:0005525 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | 6.59e-05 | 109 | 80 | 5 | GO:0090630 | |
| GeneOntologyBiologicalProcess | transposable element silencing by mRNA destabilization | 1.47e-04 | 5 | 80 | 2 | GO:0141008 | |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.54e-04 | 27 | 80 | 3 | GO:0035235 | |
| GeneOntologyBiologicalProcess | atrioventricular valve morphogenesis | 1.72e-04 | 28 | 80 | 3 | GO:0003181 | |
| GeneOntologyBiologicalProcess | atrioventricular valve development | 2.57e-04 | 32 | 80 | 3 | GO:0003171 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DDR1 CDK5R1 CYFIP1 OLFM1 FGF13 MARK2 MEF2A PREX2 PLXNA2 MFN1 MOV10 | 2.60e-04 | 802 | 80 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | fatty acid elongation, polyunsaturated fatty acid | 3.08e-04 | 7 | 80 | 2 | GO:0034626 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, monounsaturated fatty acid | 3.08e-04 | 7 | 80 | 2 | GO:0034625 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, unsaturated fatty acid | 3.08e-04 | 7 | 80 | 2 | GO:0019368 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DDR1 CDK5R1 CYFIP1 OLFM1 FGF13 MARK2 MEF2A PREX2 PLXNA2 MFN1 MOV10 | 3.11e-04 | 819 | 80 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | 3.22e-04 | 335 | 80 | 7 | GO:0043087 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DDR1 CDK5R1 CYFIP1 OLFM1 FGF13 MARK2 MEF2A PREX2 PLXNA2 MFN1 MOV10 | 3.34e-04 | 826 | 80 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | very long-chain fatty acid metabolic process | 3.36e-04 | 35 | 80 | 3 | GO:0000038 | |
| MousePheno | fused cornea and lens | 7.97e-08 | 24 | 66 | 5 | MP:0001307 | |
| MousePheno | increased circulating potassium level | 9.43e-08 | 121 | 66 | 8 | MP:0005627 | |
| MousePheno | abnormal circulating potassium level | 1.34e-06 | 171 | 66 | 8 | MP:0002668 | |
| MousePheno | abnormal potassium level | 3.71e-06 | 196 | 66 | 8 | MP:0020887 | |
| MousePheno | abnormal potassium ion homeostasis | 4.00e-06 | 198 | 66 | 8 | MP:0011978 | |
| MousePheno | abnormal tooth morphology | 1.73e-05 | 318 | 66 | 9 | MP:0002100 | |
| MousePheno | abnormal dental arch morphology | 1.77e-05 | 319 | 66 | 9 | MP:0030254 | |
| MousePheno | abnormal skin coloration | 2.30e-05 | 182 | 66 | 7 | MP:0011239 | |
| MousePheno | abnormal iris morphology | 3.25e-05 | 192 | 66 | 7 | MP:0001322 | |
| MousePheno | abnormal lens development | 3.25e-05 | 78 | 66 | 5 | MP:0005545 | |
| MousePheno | abnormal anterior uvea morphology | 4.08e-05 | 199 | 66 | 7 | MP:0005194 | |
| MousePheno | absent pinna reflex | 6.15e-05 | 89 | 66 | 5 | MP:0006358 | |
| MousePheno | cornea opacity | 1.02e-04 | 159 | 66 | 6 | MP:0001314 | |
| MousePheno | abnormal pinna reflex | 1.12e-04 | 101 | 66 | 5 | MP:0001485 | |
| MousePheno | abnormal uvea morphology | 1.36e-04 | 241 | 66 | 7 | MP:0005197 | |
| MousePheno | increased circulating mineral level | AGAP5 A1CF TENM4 GPR22 WWP1 REN AGAP11 AGAP9 AGAP7P AGAP4 ABCG8 | 1.51e-04 | 626 | 66 | 11 | MP:0014547 |
| MousePheno | hemoglobinuria | 2.18e-04 | 5 | 66 | 2 | MP:0000315 | |
| MousePheno | decreased susceptibility to age-related hepatic steatosis | 2.18e-04 | 5 | 66 | 2 | MP:0031270 | |
| MousePheno | increased mineral level | AGAP5 A1CF TENM4 GPR22 WWP1 REN AGAP11 AGAP9 AGAP7P AGAP4 ABCG8 | 2.66e-04 | 668 | 66 | 11 | MP:0014535 |
| MousePheno | abnormal mouth morphology | AGAP5 STAG1 SLC6A5 IDE AGAP11 AGAP9 AGAP7P HSD17B4 MDM2 AGAP4 AXIN2 | 2.73e-04 | 670 | 66 | 11 | MP:0000452 |
| MousePheno | cataract | AGAP5 ELOVL5 AGAP11 KATNAL1 AGAP9 AGAP7P HSD17B4 AGAP4 ABCG8 | 5.15e-04 | 497 | 66 | 9 | MP:0001304 |
| MousePheno | abnormal head morphology | DDR1 AGAP5 STAG1 SLC6A5 TTC21B IDE AGAP11 AGAP9 AGAP7P HSD17B4 MDM2 AGAP4 REXO1 AXIN2 | 6.17e-04 | 1120 | 66 | 14 | MP:0000432 |
| Domain | ArfGap | 1.48e-07 | 29 | 81 | 5 | SM00105 | |
| Domain | ArfGap | 1.48e-07 | 29 | 81 | 5 | PF01412 | |
| Domain | ARFGAP | 1.48e-07 | 29 | 81 | 5 | PS50115 | |
| Domain | ArfGAP | 1.48e-07 | 29 | 81 | 5 | IPR001164 | |
| Domain | TPR_REGION | 8.15e-05 | 165 | 81 | 6 | PS50293 | |
| Domain | TPR | 8.15e-05 | 165 | 81 | 6 | PS50005 | |
| Domain | PH | 2.04e-04 | 278 | 81 | 7 | SM00233 | |
| Domain | PH_DOMAIN | 2.09e-04 | 279 | 81 | 7 | PS50003 | |
| Domain | PH_domain | 2.13e-04 | 280 | 81 | 7 | IPR001849 | |
| Domain | - | 2.80e-04 | 207 | 81 | 6 | 1.25.40.10 | |
| Domain | ELO | 3.85e-04 | 7 | 81 | 2 | PF01151 | |
| Domain | ELO | 3.85e-04 | 7 | 81 | 2 | PS01188 | |
| Domain | ELO_fam | 3.85e-04 | 7 | 81 | 2 | IPR002076 | |
| Domain | TPR-contain_dom | 4.90e-04 | 150 | 81 | 5 | IPR013026 | |
| Domain | TPR-like_helical_dom | 5.26e-04 | 233 | 81 | 6 | IPR011990 | |
| Domain | ANF_lig-bd_rcpt | 5.49e-04 | 37 | 81 | 3 | IPR001828 | |
| Domain | ANF_receptor | 5.49e-04 | 37 | 81 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 6.42e-04 | 39 | 81 | 3 | IPR028082 | |
| Domain | Ankyrin_rpt-contain_dom | 8.26e-04 | 254 | 81 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 8.26e-04 | 254 | 81 | 6 | PS50297 | |
| Domain | DUF4599 | 1.19e-03 | 12 | 81 | 2 | PF15371 | |
| Domain | DUF4599 | 1.19e-03 | 12 | 81 | 2 | IPR027970 | |
| Domain | TPR_8 | 1.57e-03 | 53 | 81 | 3 | PF13181 | |
| Domain | EXOIII | 1.63e-03 | 14 | 81 | 2 | SM00479 | |
| Domain | Exonuclease_RNaseT/DNA_pol3 | 1.63e-03 | 14 | 81 | 2 | IPR013520 | |
| Domain | RNase_T | 1.63e-03 | 14 | 81 | 2 | PF00929 | |
| Domain | TPR | 2.40e-03 | 129 | 81 | 4 | SM00028 | |
| Domain | PH_dom-like | 2.49e-03 | 426 | 81 | 7 | IPR011993 | |
| Domain | TPR_repeat | 2.68e-03 | 133 | 81 | 4 | IPR019734 | |
| Domain | Iontro_rcpt | 2.72e-03 | 18 | 81 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 2.72e-03 | 18 | 81 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 2.72e-03 | 18 | 81 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 2.72e-03 | 18 | 81 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 2.72e-03 | 18 | 81 | 2 | SM00918 | |
| Domain | Lig_chan | 2.72e-03 | 18 | 81 | 2 | PF00060 | |
| Domain | PBPe | 2.72e-03 | 18 | 81 | 2 | SM00079 | |
| Domain | PH | 3.19e-03 | 229 | 81 | 5 | PF00169 | |
| Domain | P-loop_NTPase | 3.58e-03 | 848 | 81 | 10 | IPR027417 | |
| Domain | - | 4.48e-03 | 248 | 81 | 5 | 1.25.40.20 | |
| Domain | ANK | 4.71e-03 | 251 | 81 | 5 | SM00248 | |
| Domain | ANK_REPEAT | 4.87e-03 | 253 | 81 | 5 | PS50088 | |
| Domain | - | 4.94e-03 | 746 | 81 | 9 | 3.40.50.300 | |
| Domain | Ankyrin_rpt | 5.63e-03 | 262 | 81 | 5 | IPR002110 | |
| Domain | - | 7.03e-03 | 391 | 81 | 6 | 2.30.29.30 | |
| Pathway | REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM | 1.84e-05 | 13 | 58 | 3 | MM14821 | |
| Pathway | REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM | 1.84e-05 | 13 | 58 | 3 | M27114 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 8.57e-12 | 9 | 83 | 5 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.71e-11 | 10 | 83 | 5 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 3.13e-11 | 11 | 83 | 5 | 15381706 | |
| Pubmed | 8.68e-11 | 13 | 83 | 5 | 27713690 | ||
| Pubmed | 1.35e-10 | 14 | 83 | 5 | 22453919 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.84e-07 | 281 | 83 | 8 | 28706196 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | CNOT6 AGAP5 TENM4 STAG1 MYO1E AGAP11 MARK2 AGAP9 AGAP7P AGAP4 | 6.18e-07 | 536 | 83 | 10 | 15840001 |
| Pubmed | CNOT6 AGAP5 TENM4 STAG1 MYO1E AGAP11 MARK2 AGAP9 AGAP7P AGAP4 | 6.39e-07 | 538 | 83 | 10 | 10512203 | |
| Pubmed | 9.10e-07 | 430 | 83 | 9 | 32581705 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PASK DDR1 NR2C2 TMEM168 LPCAT3 WWP1 ELOVL5 ATP11C MARK2 MDM2 PC P3H4 PLIN2 | 1.35e-06 | 1061 | 83 | 13 | 33845483 |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32167205 | ||
| Pubmed | Identification and expression of mammalian long-chain PUFA elongation enzymes. | 5.63e-06 | 2 | 83 | 2 | 12371743 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30825095 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14636670 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28119060 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25240193 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30914501 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28245901 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 28461495 | ||
| Pubmed | Genetic Interaction of Thm2 and Thm1 Shapes Postnatal Craniofacial Bone. | 5.63e-06 | 2 | 83 | 2 | 35645293 | |
| Pubmed | 5.81e-06 | 405 | 83 | 8 | 38187761 | ||
| Pubmed | 8.93e-06 | 116 | 83 | 5 | 30652415 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CNOT6 EFHC1 CYFIP1 COPZ1 MYO1E LPCAT3 TTC21A TTC21B ELOVL5 MARK2 EDRF1 MOV10 KIF1C | 1.44e-05 | 1321 | 83 | 13 | 27173435 |
| Pubmed | Uridylation by TUT4/7 Restricts Retrotransposition of Human LINE-1s. | 1.69e-05 | 3 | 83 | 2 | 30122351 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 29267372 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28878120 | ||
| Pubmed | Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction. | 1.69e-05 | 3 | 83 | 2 | 27228353 | |
| Pubmed | Role of cardiac mitofusins in cardiac conduction following simulated ischemia-reperfusion. | 1.69e-05 | 3 | 83 | 2 | 36473917 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 34688145 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28193895 | ||
| Pubmed | Thm2 interacts with paralog, Thm1, and sensitizes to Hedgehog signaling in postnatal skeletogenesis. | 1.69e-05 | 3 | 83 | 2 | 33683377 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 28745540 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27265727 | ||
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 26386426 | ||
| Pubmed | Mitochondrial fusion is essential for organelle function and cardiac homeostasis. | 3.37e-05 | 4 | 83 | 2 | 22052916 | |
| Pubmed | 3.37e-05 | 4 | 83 | 2 | 10970790 | ||
| Pubmed | 3.95e-05 | 529 | 83 | 8 | 14621295 | ||
| Pubmed | Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death. | 5.60e-05 | 5 | 83 | 2 | 17591690 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 30617251 | ||
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 8288598 | ||
| Pubmed | Molecular basis for ubiquitin ligase CRL2FEM1C-mediated recognition of C-degron. | 5.60e-05 | 5 | 83 | 2 | 33398170 | |
| Pubmed | 5.60e-05 | 5 | 83 | 2 | 25600785 | ||
| Pubmed | Cyclin-dependent kinase 5 regulates PSD-95 ubiquitination in neurons. | 8.39e-05 | 6 | 83 | 2 | 21849563 | |
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 24749734 | ||
| Pubmed | 8.39e-05 | 6 | 83 | 2 | 34615546 | ||
| Pubmed | 1.13e-04 | 39 | 83 | 3 | 24095980 | ||
| Pubmed | Increased proximal bifurcation of CA1 pyramidal apical dendrites in sema3A mutant mice. | 1.17e-04 | 7 | 83 | 2 | 19655386 | |
| Pubmed | 1.17e-04 | 7 | 83 | 2 | 19837266 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | CNOT6 AGAP5 CYFIP1 REN IDE AGAP11 AGAP9 AGAP7P AGAP4 PLXNA2 PLIN2 | 1.77e-04 | 1242 | 83 | 11 | 30973865 |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.80e-04 | 218 | 83 | 5 | 33378226 | |
| Pubmed | 1.81e-04 | 493 | 83 | 7 | 15368895 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 2.00e-04 | 9 | 83 | 2 | 9051806 | |
| Pubmed | ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. | 2.50e-04 | 10 | 83 | 2 | 20937905 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 2.81e-04 | 704 | 83 | 8 | 29955894 | |
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 23689133 | ||
| Pubmed | 3.05e-04 | 11 | 83 | 2 | 7558021 | ||
| Pubmed | 3.13e-04 | 382 | 83 | 6 | 29222160 | ||
| Pubmed | 4.07e-04 | 60 | 83 | 3 | 32027825 | ||
| Pubmed | 4.28e-04 | 750 | 83 | 8 | 11230166 | ||
| Pubmed | 4.31e-04 | 13 | 83 | 2 | 27249653 | ||
| Pubmed | 4.31e-04 | 13 | 83 | 2 | 18172165 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 4.31e-04 | 13 | 83 | 2 | 20859245 | |
| Pubmed | 4.31e-04 | 13 | 83 | 2 | 25218043 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 4.44e-04 | 754 | 83 | 8 | 33060197 | |
| Pubmed | Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure. | 5.03e-04 | 14 | 83 | 2 | 24161931 | |
| Pubmed | Ptf1a determines GABAergic over glutamatergic neuronal cell fate in the spinal cord dorsal horn. | 5.03e-04 | 14 | 83 | 2 | 16291784 | |
| Pubmed | Comparative mapping of two adjacent regions of MMU19 with their human counterpart on HSA11q13. | 5.79e-04 | 15 | 83 | 2 | 9730611 | |
| Pubmed | 5.79e-04 | 15 | 83 | 2 | 18327258 | ||
| Pubmed | CYFIP1 TENM4 MYO1E SACS TTC21A MRPL48 GRIA2 FGF13 MARK2 PC NT5DC3 | 5.87e-04 | 1431 | 83 | 11 | 37142655 | |
| Pubmed | Corrected centromere orientation for mouse chromosome 19 MIT markers. | 6.61e-04 | 16 | 83 | 2 | 8499657 | |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 6.94e-04 | 72 | 83 | 3 | 25917818 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DDR1 TECPR2 LPCAT3 WWP1 TTC21A TTC21B TTC17 FGF13 IDE KATNAL1 MEF2A | 8.14e-04 | 1489 | 83 | 11 | 28611215 |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 8.40e-04 | 18 | 83 | 2 | 18311135 | |
| Pubmed | 8.40e-04 | 18 | 83 | 2 | 1358795 | ||
| Pubmed | 8.43e-04 | 832 | 83 | 8 | 36724073 | ||
| Pubmed | 9.90e-04 | 317 | 83 | 5 | 30997501 | ||
| Pubmed | 1.04e-03 | 20 | 83 | 2 | 17916349 | ||
| Pubmed | Mdm4 controls ureteric bud branching via regulation of p53 activity. | 1.15e-03 | 21 | 83 | 2 | 32464196 | |
| Pubmed | 1.15e-03 | 21 | 83 | 2 | 37005481 | ||
| Pubmed | Circular RNA profile in liver tissue of EpCAM knockout mice. | 1.26e-03 | 22 | 83 | 2 | 31524221 | |
| Pubmed | 1.26e-03 | 22 | 83 | 2 | 34905510 | ||
| Pubmed | 1.38e-03 | 23 | 83 | 2 | 17644613 | ||
| Pubmed | 1.38e-03 | 23 | 83 | 2 | 28031177 | ||
| Pubmed | 1.42e-03 | 202 | 83 | 4 | 29540532 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.49e-03 | 910 | 83 | 8 | 36736316 | |
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.50e-03 | 24 | 83 | 2 | 35746896 | |
| Pubmed | 1.50e-03 | 24 | 83 | 2 | 37543677 | ||
| Pubmed | 1.50e-03 | 24 | 83 | 2 | 22632720 | ||
| Pubmed | The Maternal Microbiome Programs the m6A Epitranscriptome of the Mouse Fetal Brain and Intestine. | 1.63e-03 | 25 | 83 | 2 | 35874829 | |
| Pubmed | Dissecting Wnt/beta-catenin signaling during gastrulation using RNA interference in mouse embryos. | 1.63e-03 | 25 | 83 | 2 | 15857914 | |
| Pubmed | 1.69e-03 | 720 | 83 | 7 | 16381901 | ||
| Pubmed | 1.71e-03 | 722 | 83 | 7 | 15489336 | ||
| Pubmed | 1.76e-03 | 533 | 83 | 6 | 25544563 | ||
| Pubmed | Examination of genetic polymorphisms in newborns for signatures of sex-specific prenatal selection. | 1.85e-03 | 101 | 83 | 3 | 20587610 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.85e-03 | 101 | 83 | 3 | 23382219 | |
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 1.90e-03 | 27 | 83 | 2 | 25269881 | |
| Pubmed | IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5. | 1.97e-03 | 221 | 83 | 4 | 31950832 | |
| Pubmed | 2.00e-03 | 547 | 83 | 6 | 37267103 | ||
| Pubmed | 2.04e-03 | 28 | 83 | 2 | 8944226 | ||
| Pubmed | 2.04e-03 | 28 | 83 | 2 | 30947518 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q11 | 3.89e-04 | 188 | 83 | 4 | chr10q11 | |
| Cytoband | 9q21.32 | 5.41e-04 | 19 | 83 | 2 | 9q21.32 | |
| Cytoband | 10q11.23 | 1.64e-03 | 33 | 83 | 2 | 10q11.23 | |
| Cytoband | 10q11.22 | 2.53e-03 | 41 | 83 | 2 | 10q11.22 | |
| GeneFamily | ArfGAPs | 3.98e-08 | 33 | 53 | 5 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.52e-07 | 17 | 53 | 4 | 1291 | |
| GeneFamily | Ankyrin repeat domain containing | 7.33e-05 | 242 | 53 | 6 | 403 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.37e-04 | 206 | 53 | 5 | 682 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 3.58e-04 | 115 | 53 | 4 | 769 | |
| GeneFamily | Exonucleases | 9.85e-04 | 16 | 53 | 2 | 544 | |
| GeneFamily | Intraflagellar transport proteins|Tetratricopeptide repeat domain containing | 2.23e-03 | 24 | 53 | 2 | 615 | |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 9.42e-08 | 37 | 80 | 5 | MM1121 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 2.31e-07 | 44 | 80 | 5 | MM485 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN | 1.29e-06 | 179 | 80 | 7 | M8928 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 2.69e-06 | 200 | 80 | 7 | M9628 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN | 3.44e-05 | 200 | 80 | 6 | M6626 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP | 3.44e-05 | 200 | 80 | 6 | M6531 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 4.40e-05 | 209 | 80 | 6 | MM1058 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.89e-06 | 200 | 82 | 6 | 0cb0755a101ec655359d051d6a8807408d727c55 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.75e-05 | 174 | 82 | 5 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 178 | 82 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-05 | 182 | 82 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.35e-05 | 185 | 82 | 5 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-05 | 187 | 82 | 5 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.67e-05 | 190 | 82 | 5 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 191 | 82 | 5 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-05 | 197 | 82 | 5 | 10e72b425a2bcba35e63a5b074d3dedcd49a762e | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-05 | 199 | 82 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.33e-05 | 199 | 82 | 5 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4-L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | e2ced6eb1de9a526c34c7558b9c637854916e624 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | c7e33057466915d4e2b34f2062b22d9cdffa69dc | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-CHRNA4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.41e-05 | 200 | 82 | 5 | 9bc924755e5a4c464408e6103b86bf1b4e8c58b5 | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.83e-11 | 10 | 78 | 5 | DOID:1969 (implicated_via_orthology) | |
| Disease | Schizophrenia | DDR1 CDK5R1 CYFIP1 TENM4 SLC6A5 GRIA2 GRIK4 IDE MARK2 TAP2 PLXNA2 | 2.02e-05 | 883 | 78 | 11 | C0036341 |
| Disease | nephronophthisis (implicated_via_orthology) | 2.45e-04 | 9 | 78 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | atopic eczema, childhood onset asthma, atopic march | 3.74e-04 | 11 | 78 | 2 | EFO_0000274, EFO_0007755, MONDO_0005405 | |
| Disease | campesterol measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0020008 | |
| Disease | amino acid measurement | 4.25e-04 | 678 | 78 | 8 | EFO_0005134 | |
| Disease | Colorectal Carcinoma | 5.34e-04 | 702 | 78 | 8 | C0009402 | |
| Disease | fatty acid measurement, linoleic acid measurement | 7.87e-04 | 68 | 78 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | Nonorganic psychosis | 8.21e-04 | 69 | 78 | 3 | C0349204 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 8.92e-04 | 71 | 78 | 3 | EFO_0001645, EFO_0004791 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.05e-03 | 75 | 78 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | Manic | 1.17e-03 | 78 | 78 | 3 | C0338831 | |
| Disease | Depression, Bipolar | 1.22e-03 | 79 | 78 | 3 | C0005587 | |
| Disease | platelet measurement | 1.50e-03 | 315 | 78 | 5 | EFO_0005036 | |
| Disease | Bipolar Disorder | 1.66e-03 | 477 | 78 | 6 | C0005586 | |
| Disease | response to antiviral drug, cirrhosis of liver | 1.83e-03 | 24 | 78 | 2 | EFO_0001422, EFO_0010123 | |
| Disease | Brain Diseases | 1.99e-03 | 25 | 78 | 2 | C0006111 | |
| Disease | psychosis predisposition measurement | 2.15e-03 | 26 | 78 | 2 | EFO_0008337 | |
| Disease | Encephalopathies | 2.32e-03 | 27 | 78 | 2 | C0085584 | |
| Disease | Psychotic Disorders | 2.46e-03 | 101 | 78 | 3 | C0033975 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.49e-03 | 28 | 78 | 2 | DOID:1094 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NYSMAITYYEAALKT | 771 | Q7Z4L5 | |
| SNGVLTYYSSLGDYM | 286 | Q96P64 | |
| MLKESNFADSYYDYI | 116 | Q8IV48 | |
| VLTYYSSLGDYMKNI | 151 | Q8TF27 | |
| GVLTYYSSLGDYMKN | 356 | Q5VTM2 | |
| LLTCLYLSYSYMGNE | 226 | Q15078 | |
| YLSYSYMGNEISYPL | 231 | Q15078 | |
| TMLQGEYTYSLGQVY | 321 | Q9NQ94 | |
| TLELYTSYLYLSMAF | 26 | Q9BXU8 | |
| TMYLSEAVYLNDSTY | 201 | Q08345 | |
| AMLYYELEDGLYTTG | 476 | Q9H221 | |
| AYQMFLTSDIYLEYV | 186 | Q9Y2T1 | |
| AYDPYLIAMSSIYLA | 66 | Q8N1B3 | |
| SMAKLDIDGYEYAYL | 481 | P49116 | |
| YSTFQMYLDTELSYP | 126 | P25092 | |
| YQDSVYYIDTLGRIM | 71 | Q96RS6 | |
| SVSLTMYGALYLYER | 616 | Q8IWA4 | |
| MEYVLYSLDLYNDSA | 661 | Q7L576 | |
| FATLMAYEVYYGLTE | 446 | Q86U38 | |
| PGFYSYMDLAYNSSL | 386 | Q96RG2 | |
| NGSVMSLYNICYYAL | 301 | A0A1B0GTS1 | |
| TLNSFIHVLMYSYYG | 171 | Q9NYP7 | |
| YYVLSDAAMSLQKYG | 696 | Q3B7T1 | |
| AMDNYECNLYTFLYL | 436 | Q9UK73 | |
| YAYLLESTMNEYIEQ | 721 | P42262 | |
| MLSALNEIYSYVSKY | 1846 | O75051 | |
| MAYDRYLAICQSLTY | 121 | P47883 | |
| LKTRSLDYAGYNNMY | 331 | Q99784 | |
| LYGLYDTVMSSISGY | 1281 | Q96JB1 | |
| YFYVIGSSYENELML | 76 | P61923 | |
| AQLSYSVEVSYMEIY | 136 | O43896 | |
| QMAYLLAGYYYTATG | 121 | Q6P1A2 | |
| SNEGTYYMLLLTYSG | 146 | P50748 | |
| GLVYSAMPTAYNTDY | 326 | Q02078 | |
| YFLYSGYKQEMTLIE | 31 | Q9H3R1 | |
| NGSVMSLYNICYYAL | 301 | A0A1B0GWH4 | |
| SYVYKSLMTFGGYQD | 1391 | Q8IVE3 | |
| ECYLLSSMAYDRYAA | 111 | Q8N146 | |
| NSFIHILMYSYYGLS | 176 | Q9NXB9 | |
| YPVTESSYSAYAIML | 121 | O60883 | |
| SYAYTELEAIMYALG | 336 | P51659 | |
| SNGVLTYYSSLGDYM | 286 | Q5VUJ5 | |
| YNEVMATYLLLGYKS | 351 | Q7KZI7 | |
| NIYYYLEDDSMSVIE | 121 | Q5JVL4 | |
| LYLAMNSEGYLYTSE | 121 | Q92913 | |
| LSYDLQNTIYGMYLS | 616 | P14735 | |
| SNYAFLLESTMNEYY | 716 | Q16099 | |
| LCVSTNEYYTELGMY | 196 | Q99680 | |
| YNSSYMYEKESELIQ | 286 | Q9UKT9 | |
| LATSGELMDYTYYAV | 1931 | Q9NZJ4 | |
| AYESGLMPYTNYTFD | 471 | Q9ULM6 | |
| AALYSGYNIEQIMYL | 611 | Q13423 | |
| VSLTVYTLFMIDGYY | 436 | Q8WU17 | |
| YALLGNYDSSMVYYQ | 16 | Q9BW62 | |
| YALDCEMSYTTYGLE | 1061 | Q8N1G1 | |
| GFLLMYSTVLCSYYN | 251 | Q76EJ3 | |
| IYMFQLVDTYAASYA | 626 | Q9Y345 | |
| KGYDLELSMALGTYY | 281 | Q9HCE1 | |
| MSLSDIEIYGFDYDY | 91 | Q86UY8 | |
| VILTNYMDTQYYGEI | 76 | P00797 | |
| DTYTMKEVLFYLGQY | 46 | Q00987 | |
| TAYDMTLAESYAQYV | 96 | Q96GC5 | |
| SYVQTLVYIYGDMLS | 421 | Q03519 | |
| YLFYMVLTLYSSPTE | 41 | Q6ZUB0 | |
| AALSIYSALYATMYI | 201 | Q8TBJ4 | |
| GVLTYYSSLGDYMKN | 311 | A6NIR3 | |
| YDAAYLTMYNICFTS | 906 | Q8NB49 | |
| YLFYMVLTLYSSPTE | 41 | P0C874 | |
| YLNYYQGMLDVADES | 181 | Q92791 | |
| LYTAYGEIYMDTNPN | 2381 | Q6N022 | |
| MYSDAFLNDSYLKYV | 321 | Q8WVM7 | |
| VLFAQALESMEGYYY | 1406 | Q70Z35 | |
| DYIAVGSSIGMLYLY | 46 | O15040 | |
| LYYYFSMEAASLSLS | 81 | Q9H0V1 | |
| TSYYTLGNIYAMLGE | 296 | Q96AE7 | |
| SSLMAGIIYYSQEKY | 6 | Q8NDW8 | |
| ASTMLGDIYNEKGYY | 356 | Q8NA56 | |
| YDLMSSAYLSTKDQY | 26 | Q99541 | |
| LIYYAYQTMSLADAT | 146 | Q2M3R5 | |
| ISSVFSDYYDLGYNM | 191 | O43247 | |
| YLYSASMLAAENDPY | 441 | Q9H0M0 | |
| GSLSSYAYTLMVLYF | 1166 | Q5VYS8 | |
| TKYSLQYYMGLAEEL | 716 | P11498 | |
| NAYTAMSDSYLPSYY | 46 | Q9Y5A9 | |
| SLGITSMDYYYYLSL | 226 | Q12965 |